Atlas Trials

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Clinical trial NCT01638533 · COMPLETED

Trial details

NCT number
NCT01638533
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
GliomaHematopoietic and Lymphoid Cell NeoplasmLymphomaMetastatic Malignant Solid NeoplasmNeuroendocrine NeoplasmRecurrent Adult Soft Tissue SarcomaRecurrent Bladder CarcinomaRecurrent Breast CarcinomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Colorectal CarcinomaRecurrent Head and Neck CarcinomaRecurrent Lung Carcinoma
Start date
2012-08-03
Primary completion
2018-11-29
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.